Document is current

Any future updates will be listed below

Einsatz von Dupilumab bei COPD mit eosinophiler Inflammation

Crossref DOI link: https://doi.org/10.1007/s15033-024-4037-3

Published Online: 2024-09-06

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark